Target intelligence / Profile preview

AC000123.3 (TEC) (AC000123.3)

Target
AC000123.3
Molecular classification
Other (novel transcript; not classified as receptor, enzyme, transporter, ion channel, transcription factor, etc.)
01

Overview

This target corresponds to an Ensembl gene ID (ENSG00000280347)—annotated as AC000123.3 (TEC)—which, according to available gene and transcript databases, is a novel transcript and does not encode a well-characterized protein. There is no evidence supporting a functional protein product, biological activity, or clinical relevance that would qualify it as a therapeutic target, receptor, enzyme, or biomarker. Differential RNA expression in Alzheimer’s disease brain regions has been observed, but there is no confirmed genetic or proteomic association with disease, nor nomination as a curated target for therapeutic intervention. It is not classified in major molecular families (such as G protein-coupled receptors, enzymes, ion channels, or transcription factors) and lacks reported molecular function, disease association, or drug interaction data[1][3]. Summary findings: - This gene symbol represents an uncharacterized or non-coding transcript, not a standard drug target. - No functional, pharmacologic, or disease-relevant information is documented in authoritative databases. - Its primary listing is as a genome annotation without supporting experimental evidence for targetability in medicine or biology[1][3].

Other names
AC000123.3TEC

Beyond the preview

Go deeper on AC000123.3 (TEC) (AC000123.3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AC000123.3 (TEC) (AC000123.3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call